Serum paraoxonase, TAS, TOS and ceruloplasmin in brucellosis
dc.contributor.author | Demirpence, Ozlem | |
dc.contributor.author | Sevim, Bunyamin | |
dc.contributor.author | Yildirim, Mustafa | |
dc.contributor.author | Nurlu, Nilhan Ayan | |
dc.contributor.author | Mert, Duygu | |
dc.contributor.author | Evliyaoglu, Osman | |
dc.date.accessioned | 2024-04-24T17:38:03Z | |
dc.date.available | 2024-04-24T17:38:03Z | |
dc.date.issued | 2014 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | It is possible that brucellosis may be related to increase free radical production and antioxidant depletion. Thus, in the present study we aimed to evaluate the oxidative status in patient with brucellosis and healthy controls. Methods: This study includes the patients with brucellosis diagnosed by clinical findings and positive agglutination titer. The paraoxonase, ceruloplasmin, total antioxidant capacity and total oxidant status values were measured from the samples taken. The oxidative stress index value was calculated through the total antioxidant capacity and total oxidant status values. Results: A total number of 93 people, 40 women (43%) and 53 men (57%) were included to the study. The levels of ceruloplasmin were found higher in patients when compared to the control group (p < 0.001). The total antioxidant capacity level was found significantly higher in the patients group when compared to the control group (p < 0.001). The oxidative stress index value was significantly lower in the patients group when compared to the control group (p < 0.001). The paraoxonase-1 level was not different in control and patient groups (p = 0.077). Conclusions: Brucellosis is an infection that is frequently seen in Mediterranean countries. This infection breaks the oxidant and antioxidant balance. In this disease, oxidant-antioxidant system indicators such as ceruloplasmin, total antioxidant capacity, total oxidant status and oxidative stress index can be used for showing the role of the brucella infection and for the monitoring of the treatment results. | en_US |
dc.identifier.endpage | 1597 | en_US |
dc.identifier.issn | 1940-5901 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 25035784 | |
dc.identifier.scopus | 2-s2.0-84904057795 | |
dc.identifier.scopusquality | N/A | |
dc.identifier.startpage | 1592 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/21305 | |
dc.identifier.volume | 7 | en_US |
dc.identifier.wos | WOS:000341255900014 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | E-Century Publishing Corp | en_US |
dc.relation.ispartof | International Journal of Clinical and Experimental Medicine | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Brucella | en_US |
dc.subject | Total Antioxidant Capacity | en_US |
dc.subject | Total Oxidant Status | en_US |
dc.subject | Paraoxonase | en_US |
dc.subject | Ceruloplasmin | en_US |
dc.title | Serum paraoxonase, TAS, TOS and ceruloplasmin in brucellosis | en_US |
dc.title | Serum paraoxonase, TAS, TOS and ceruloplasmin in brucellosis | |
dc.type | Article | en_US |